Gokalp O., Gulle K., Sulak O., Cicek E., Altuntas I
Some patients with the disease do drink alcohol, for instance
These changes arise from actual changes in the bodys food processing and fuel burning
Both groups took the 2.5 mg tablet once daily for 28 days
After a median follow-up of 2 years, the incidence of new or worsening nephropathy in the semaglutide group was lower than that in the placebo group [HR 0.64 (95% CI: 0.460.88, p=0.05)]
Use of lower (7.5% [58 mmol/mol]) and higher (8.5% [69 mmol/mol]) HbA1c intensification thresholds led to reduced (0.11 QALYs) and improved (0.31 QALYs) incremental quality-adjusted life expectancy with oral semaglutide, respectively, while application of a fixed 3-year treatment duration with linear HbA1c progression yielded similar incremental quality-of-life outcomes to the base case (0.18 QALYs)